← Evidence map

ArticleExperimental hematology & oncology2021

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma.

Patrick B Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 33602316